Sign in Pull a receipt

TARS

Tarsus Pharmaceuticals, Inc.

Pharmaceuticals · Pharmaceuticals

$140.44 sample

+2.09 (+1.51%) 1D

Market cap

$830.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$140.44 +7.82% 3M daily closessample

140.44121.45

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: EVP, Operations
Oct 16SECForm 144 filed
Oct 12INSInsider sell: EVP, Operations
Oct 02INSInsider buy: Chief Executive Officer
Sep 29INSInsider buy: 10% owner
Sep 22SECForm 144 filed
Sep 17INSInsider buy: EVP, Operations
Sep 09INSInsider sell: 10% owner

Sign up to see the real TARS record →

Company facts

SEC EDGAR registration

Name: Tarsus Pharmaceuticals, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +47sample, -100 to +100
Reporting currency: USD

Who is positioning in TARS

sample

Insiders: 14 insider transactions over 90 days, net selling, $800.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 38 funds hold $6.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.8B +10.9% y/y

Q4 2024Q3 2026

Inventory$16.3B +9.9% y/y

Q4 2024Q3 2026

Accounts receivable$12.5B +13.9% y/y

Q4 2024Q3 2026

Total debt$31.6B +10.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $209.3B +11.9% 3M
Sample peer B: $362.9B +10.0% 3M
Sample peer C: $770.3B +2.3% 3M
Sample peer D: $639.6B -8.6% 3M
Sample peer E: $658.3B +4.3% 3M